Icon plc, a provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced the appointment of Mary Pendergast as a non-executive director.
According to a release, Pendergast is President of Pendergast Consulting. Prior to founding her own firm, Pendergast was Executive Vice President of Government Affairs at Elan Corp. from 1998 to 2003. Pendergast also spent more than 18 years at the US Food and Drug Administration, serving as Deputy Commissioner and Senior Advisor to the FDA Commissioner and Associate Chief Counsel for Enforcement.
Pendergast is also a board member of AesRx, ARCH Foundation and Impax Laboratories, Inc.
"We are delighted to welcome Ms. Pendergast to the Icon Board," said Chairman, Thomas Lynch. "Her deep knowledge and understanding of the regulatory environment within the biopharma and medical device industries will be a great asset to the Board and will complement the expertise of our existing Board members."
Icon plc is a provider of outsourced development services.
((Comments on this story may be sent to email@example.com))